Abbott has secured the US FDA approval for its next generation CardioMEMS HERO device, which is designed to support remote heart failure monitoring.

Medtech companies like BlueWind or Medtronic are increasingly investing in neuromodulation to treat urgency urinary incontinence (UUI).

Synergy Spine Solutions has received PMA from the FDA for the Synergy Disc, expanding cervical disc replacement options for US patients.

The proposed IPO could see MiniMed offer 28m shares as the company looks to reach profitability independently of Medtronic.

Thermo Fisher’s LDT offers clinicians’ deeper insight into individual immunosuppressant dosing regimens for organ transplant ...

ProSomnus's has received funding to advance its sleep apnoea treatments, which are positioned as an alternative to CPAP.

ENDRA Life Sciences has reported results from a clinical study showing the Taeus Liver device’s high measurement consistency in MASLD.

Stryker has launched Synchfix EVT, a flexible syndesmotic fixation device intended to simplify surgical procedures and support ankle stabilisation in patients with syndesmotic disruptions.

Allurion has received the FDA clearance for PMA application for its Gastric Balloon System featuring the Allurion Smart Capsule for obesity treatment.

Science’s brain computer interface (BCI) ecosystem is a neural data platform designed to simplify partners’ development of BCI technologies.

Guardant's acquisition of MetaSight comes as analysts remain intrigued by the company’s long-term growth prospects.

Smith+Nephew has signed a distribution agreement with SI-BONE for the iFuse TORQ pelvic fracture fixation portfolio.